UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Institutional Implementation of a Structured Reporting System: Our Experience with the Brain Tumor Reporting and Data System

Academic radiology, 2019-07, Vol.26 (7), p.974-980

2019

Volltextzugriff (PDF)

NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma

Neuro-oncology (Charlottesville, Va.), 2024-09, Vol.26 (9), p.1628-1637

2024

Volltextzugriff (PDF)

Management-Based Structured Reporting of Posttreatment Glioma Response With the Brain Tumor Reporting and Data System

Journal of the American College of Radiology, 2018-05, Vol.15 (5), p.767-771

2018

Volltextzugriff (PDF)

Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification

Cancer, 2020-07, Vol.126 (14), p.3255-3264

2020

Volltextzugriff (PDF)

Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high‐risk grade 2 glioma: An analysis of the National Cancer Data Base

Cancer, 2018-03, Vol.124 (6), p.1169-1178

2018

Volltextzugriff (PDF)

Bevacizumab‐induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab

Cancer, 2015-05, Vol.121 (9), p.1456-1462

2015

Volltextzugriff (PDF)

Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma

Journal of neuro-oncology, 2016-10, Vol.130 (1), p.193-201

2016

Volltextzugriff (PDF)

Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma

Tomography (Ann Arbor), 2022-03, Vol.8 (2), p.688-700

2022

Volltextzugriff (PDF)

Multimodal diagnostic imaging in primary vitreoretinal lymphoma

International journal of retina and vitreous, 2022-08, Vol.8 (1), p.1-58, Article 58

2022

Volltextzugriff (PDF)

Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base

Frontiers in oncology, 2018-11, Vol.8, p.440-440

2018

Volltextzugriff (PDF)

A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma

Neuro-oncology advances, 2022-01, Vol.4 (1), p.vdac006

2022

Volltextzugriff (PDF)

Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab

Journal for immunotherapy of cancer, 2018-01, Vol.6 (1), p.11-5, Article 11

2018

Volltextzugriff (PDF)

Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma

Journal of neuro-oncology, 2008, Vol.86 (2), p.211-215

2008

Volltextzugriff (PDF)

Co-Occurrence Conundrum: Brain Metastases from Lung Adenocarcinoma, Radiation Necrosis, and Gliosarcoma

Case reports in oncology, 2021-01, Vol.14 (1), p.487-492

2021

Volltextzugriff (PDF)

Using Brain Tumor MRI Structured Reporting to Quantify the Impact of Imaging on Brain Tumor Boards

Tomography (Ann Arbor), 2023-04, Vol.9 (2), p.859-870

2023

Volltextzugriff (PDF)

A multicenter, real‐world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virus

EJHaem, 2022-08, Vol.3 (3), p.734-738

2022

Volltextzugriff (PDF)

Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma

International journal of retina and vitreous, 2021-12, Vol.7 (1), p.1-72, Article 72

2021

Volltextzugriff (PDF)

Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143

Neuro-oncology (Charlottesville, Va.), 2018-04, Vol.20 (5), p.674-686

2018

Volltextzugriff (PDF)

CN-20BEVACIZUMAB CAUSING RECURRENT CEREBRAL INFARCTION IN A PATIENT WITH GLIOBLASTOMA: A PREVIOUSLY UNDOCUMENTED PHENOMENON

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v50-v50

2014

Volltextzugriff (PDF)

Association between VTE and MGMT status in patients with high grade glioma

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e14055-e14055

2018

Volltextzugriff (PDF)

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

Annals of neurology, 2007-01, Vol.61 (1), p.25-36

2007

Volltextzugriff (PDF)

A Multicenter, Real World Analysis of Primary Central Nervous System Lymphoma in Those with and without Human Immunodeficiency Virus

Blood, 2021-11, Vol.138 (Supplement 1), p.1457-1457

2021

Volltextzugriff (PDF)

Impact of systemic therapy regimen on survival of PCNSL

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2070-2070

2022

Volltextzugriff (PDF)

ACTR-51. REMARKABLE RESPONSE OF A PATIENT WITH SECONDARY GBM TO A HISTONE DEACETYLASE INHIBITOR

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi25-vi25

2019

Volltextzugriff (PDF)

NIMG-18EVALUATING TUMOR PROGRESSION AND IMMUNOLOGIC REACTIONS DURING IMMUNOTHERAPY: NEUROIMAGING OBSERVATIONS FROM A MULTICENTER STUDY OF NIVOLUMAB MONOTHERAPY AND NIVOLUMAB IN COMBINATION WITH IPILIMUMAB IN RECURRENT GLIOBLASTOMA (CHECKMATE-143)

Neuro-oncology (Charlottesville, Va.), 2015-11, Vol.17 (suppl 5), p.v157.1-v157

2015

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Englisch
(58)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neuro-Oncology
(16)
Journal Of Clinical Oncology
(8)
Cancer
(3)
Neuro-Oncology Advances
(3)
Tomography
(3)
Blood
(2)
Brain
(2)
International Journal Of Retina And Vitreous
(2)
Journal Of Neuro-Oncology
(2)
Academic Radiology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Institutional Implementation of a Structured Reporting System: Our Experience with the Brain Tumor Reporting and Data System

NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma

Management-Based Structured Reporting of Posttreatment Glioma Response With the Brain Tumor Reporting and Data System

Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification

Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high‐risk grade 2 glioma: An analysis of the National Cancer Data Base

Bevacizumab‐induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab

Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma

Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma

Multimodal diagnostic imaging in primary vitreoretinal lymphoma

Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base

A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma

Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab

Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma

Co-Occurrence Conundrum: Brain Metastases from Lung Adenocarcinoma, Radiation Necrosis, and Gliosarcoma

Using Brain Tumor MRI Structured Reporting to Quantify the Impact of Imaging on Brain Tumor Boards

A multicenter, real‐world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virus

Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma

Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143

CN-20BEVACIZUMAB CAUSING RECURRENT CEREBRAL INFARCTION IN A PATIENT WITH GLIOBLASTOMA: A PREVIOUSLY UNDOCUMENTED PHENOMENON

Association between VTE and MGMT status in patients with high grade glioma

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

A Multicenter, Real World Analysis of Primary Central Nervous System Lymphoma in Those with and without Human Immunodeficiency Virus

Impact of systemic therapy regimen on survival of PCNSL

ACTR-51. REMARKABLE RESPONSE OF A PATIENT WITH SECONDARY GBM TO A HISTONE DEACETYLASE INHIBITOR

NIMG-18EVALUATING TUMOR PROGRESSION AND IMMUNOLOGIC REACTIONS DURING IMMUNOTHERAPY: NEUROIMAGING OBSERVATIONS FROM A MULTICENTER STUDY OF NIVOLUMAB MONOTHERAPY AND NIVOLUMAB IN COMBINATION WITH IPILIMUMAB IN RECURRENT GLIOBLASTOMA (CHECKMATE-143)

Suchergebnisse filtern